Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/OMI · Entity 6858 | Director · President & CEO | July 02, 2018 | July 03, 2018 |
| RR Donnelley & Sons CoRRD · Entity 129856 | Director | May 14, 2021 | June 03, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACCENDRA HEALTH INC/VA/
Report date July 02, 2018 · Filed July 03, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 383,229 |
Reported balance
After 2018-07-02 transaction · row 1
1 source rowRow 1 · 2018-07-02 · Tax withholding · Disposed 13,265 · Balance 383,229 F1: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person.
RR Donnelley & Sons Co
Report date May 14, 2021 · Filed June 03, 2021 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 218,763 |
Reported balance
After 2021-05-14 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2021-05-14 · Exercise / conversion · Acquired 59,420 · Balance 218,763 F1: Each share of phantom stock was the economic equivalent of one share of RRD common stock. The Issuer settled the phantom stock for cash. |
| Common StockSEC Table I · non-derivative | Direct | 159,361 |
Reported balance
After 2021-05-14 transaction · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · 2021-05-14 · Disposition to issuer · Disposed 59,420 · Balance 159,361 |
| Common StockSEC Table I · non-derivative | Direct | 184,165 |
Reported balance
After 2021-05-20 transaction · row 3
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 3 · 2021-05-20 · Grant · Acquired 24,822 · Balance 184,165 F2: Company granted restricted stock units ("RSUs") issued pursuant to Rule 16b-3 Plan. The RSUs are payable in shares of common stock on the first anniversary of the grant date or when the reporting person ceases to be a director, if earlier. |
| Phantom StockSEC Table II · derivative / convertible security · Expires 2021-05-14 | Direct | 0 |
Reported balance
After 2021-05-14 transaction · row 4
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 4 · 2021-05-14 · Exercise / conversion · Disposed 59,420 · Balance 0 F3: Represents the economic equivalent of one share of Company common stock, which may be settled in Company common stock or cash upon vesting. F5: The vested phantom stock was settled for cash. F4: Phantom stock is payable in shares of common stock or cash on the earlier of the first anniversary of the grant date or the reporting person ceasing to be a member of the board of directors of the issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of phantom stock was the economic equivalent of one share of RRD common stock. The Issuer settled the phantom stock for cash.
F2: Company granted restricted stock units ("RSUs") issued pursuant to Rule 16b-3 Plan. The RSUs are payable in shares of common stock on the first anniversary of the grant date or when the reporting person ceases to be a director, if earlier.
F3: Represents the economic equivalent of one share of Company common stock, which may be settled in Company common stock or cash upon vesting.
F4: Phantom stock is payable in shares of common stock or cash on the earlier of the first anniversary of the grant date or the reporting person ceasing to be a member of the board of directors of the issuer.
F5: The vested phantom stock was settled for cash.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2021 Filed May 24, 2021 15:57 UTC | RR Donnelley & Sons Co RRD · Entity 129856 | GrantCommon Stock | 24,822 | $5.64 | $139,996.08 |
DisclosureSEC source: 0001209191-21-035297 · doc4.xml · nonDerivative · entry 3 PHIPPS PAUL CODY · CIK 0001258393 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,183 F2 · price: Company granted restricted stock units ("RSUs") issued pursuant to Rule 16b-3 Plan. The RSUs are payable in shares of common stock on the first anniversary of the grant date or when the reporting person ceases to be a director, if earlier. Read SEC document |
| May 20, 2021 Filed Jun 3, 2021 15:43 UTC Amendment | RR Donnelley & Sons Co RRD · Entity 129856 | GrantCommon Stock | 24,822 | $5.64 | $139,996.08 |
DisclosureSEC source: 0001209191-21-037597 · doc4a.xml · nonDerivative · entry 3 PHIPPS PAUL CODY · CIK 0001258393 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,165 F2 · price: Company granted restricted stock units ("RSUs") issued pursuant to Rule 16b-3 Plan. The RSUs are payable in shares of common stock on the first anniversary of the grant date or when the reporting person ceases to be a director, if earlier. Read SEC document |
| May 14, 2021 Filed May 24, 2021 15:57 UTC | RR Donnelley & Sons Co RRD · Entity 129856 | Exercise / conversionPhantom Stock · Derivative | 59,420 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-035297 · doc4.xml · derivative · entry 4 PHIPPS PAUL CODY · CIK 0001258393 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 59,420 shares Expires 2021-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Represents the economic equivalent of one share of Company common stock, which may be settled in Company common stock or cash upon vesting. F5 · price: The vested phantom stock was settled for cash. F4 · derivative.exercise_date: Phantom stock is payable in shares of common stock or cash on the earlier of the first anniversary of the grant date or the reporting person ceasing to be a member of the board of directors of the issuer. Read SEC document |
| May 14, 2021 Filed May 24, 2021 15:57 UTC | RR Donnelley & Sons Co RRD · Entity 129856 | Disposition to issuerCommon Stock | 59,420 | $4.43 | $263,230.60 |
DisclosureSEC source: 0001209191-21-035297 · doc4.xml · nonDerivative · entry 2 PHIPPS PAUL CODY · CIK 0001258393 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,361 Read SEC document |
| May 14, 2021 Filed May 24, 2021 15:57 UTC | RR Donnelley & Sons Co RRD · Entity 129856 | Exercise / conversionCommon Stock | 59,420 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-035297 · doc4.xml · nonDerivative · entry 1 PHIPPS PAUL CODY · CIK 0001258393 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of phantom stock was the economic equivalent of one share of RRD common stock. The Issuer settled the phantom stock for cash. Read SEC document |
| May 14, 2021 Filed Jun 3, 2021 15:43 UTC Amendment | RR Donnelley & Sons Co RRD · Entity 129856 | Exercise / conversionPhantom Stock · Derivative | 59,420 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-037597 · doc4a.xml · derivative · entry 4 PHIPPS PAUL CODY · CIK 0001258393 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 59,420 shares Expires 2021-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Represents the economic equivalent of one share of Company common stock, which may be settled in Company common stock or cash upon vesting. F5 · price: The vested phantom stock was settled for cash. F4 · derivative.exercise_date: Phantom stock is payable in shares of common stock or cash on the earlier of the first anniversary of the grant date or the reporting person ceasing to be a member of the board of directors of the issuer. Read SEC document |
| May 14, 2021 Filed Jun 3, 2021 15:43 UTC Amendment | RR Donnelley & Sons Co RRD · Entity 129856 | Disposition to issuerCommon Stock | 59,420 | $4.43 | $263,230.60 |
DisclosureSEC source: 0001209191-21-037597 · doc4a.xml · nonDerivative · entry 2 PHIPPS PAUL CODY · CIK 0001258393 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,361 Read SEC document |
| May 14, 2021 Filed Jun 3, 2021 15:43 UTC Amendment | RR Donnelley & Sons Co RRD · Entity 129856 | Exercise / conversionCommon Stock | 59,420 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-037597 · doc4a.xml · nonDerivative · entry 1 PHIPPS PAUL CODY · CIK 0001258393 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of phantom stock was the economic equivalent of one share of RRD common stock. The Issuer settled the phantom stock for cash. Read SEC document |
| May 14, 2020 Filed May 18, 2020 12:11 UTC | RR Donnelley & Sons Co RRD · Entity 129856 | GrantPhantom Stock · Derivative | 59,420 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-029969 · doc4.xml · derivative · entry 2 PHIPPS PAUL CODY · CIK 0001258393 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,420 Underlying: Common Stock · 59,420 shares Expires not disclosed F3 · derivative.exercise_price: Represents the economic equivalent of one share of Company common stock, which may be settled in Company common stock or cash upon vesting. F3 · price: Represents the economic equivalent of one share of Company common stock, which may be settled in Company common stock or cash upon vesting. F4 · derivative.exercise_date: Phantom stock is payable in shares of common stock or cash on the earlier of the first anniversary of the grant date or the reporting person ceasing to be a member of the board of directors of the issuer. F4 · derivative.expiration_date: Phantom stock is payable in shares of common stock or cash on the earlier of the first anniversary of the grant date or the reporting person ceasing to be a member of the board of directors of the issuer. Read SEC document |
| May 14, 2020 Filed May 18, 2020 12:11 UTC | RR Donnelley & Sons Co RRD · Entity 129856 | GrantCommon Stock | 76,502 | $1.03 | $78,797.06 |
DisclosureSEC source: 0001209191-20-029969 · doc4.xml · nonDerivative · entry 1 PHIPPS PAUL CODY · CIK 0001258393 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,343 F1 · price: Company granted restricted stock units ("RSUs") issued pursuant to Rule 16b-3 Plan. The RSUs are payable in shares of common stock on the first anniversary of the grant date or when the reporting person ceases to be a director, if earlier. F2 · balance_after: Includes 1,861 shares held directly and 157,482 restricted stock units. Read SEC document |
| May 16, 2019 Filed May 17, 2019 16:31 UTC | RR Donnelley & Sons Co RRD · Entity 129856 | GrantCommon Stock | 48,275 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-030952 · doc4.xml · nonDerivative · entry 1 PHIPPS PAUL CODY · CIK 0001258393 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,841 F1 · price: Company granted restricted stock units ("RSUs") issued pursuant to Rule 16b-3 Plan. The RSUs are payable in shares of common stock on the third anniversary of the grant date or when the reporting person ceases to be a director, if earlier. F2 · balance_after: Includes 82,841 RSUs. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 18:29 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 13,265 | $16.71 | $221,658.15 |
DisclosureSEC source: 0000075252-18-000109 · edgar.xml · nonDerivative · entry 1 PHIPPS PAUL CODY · CIK 0001258393 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 383,229 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| May 18, 2018 Filed May 21, 2018 18:13 UTC | RR Donnelley & Sons Co RRD · Entity 129856 | GrantCommon Stock | 21,116 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-032047 · doc4.xml · nonDerivative · entry 1 PHIPPS PAUL CODY · CIK 0001258393 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,566 F1 · price: Company granted restricted stock units ("RSUs") issued pursuant to Rule 16b-3 Plan. The RSUs are payable in shares of common stock on the third anniversary of the grant date or when the reporting person ceases to be a director, if earlier. F2 · balance_after: Includes 34,566 RSUs. Read SEC document |
| February 08, 2018 Filed Feb 12, 2018 21:33 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 125,786 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-18-000038 · edgar.xml · nonDerivative · entry 1 PHIPPS PAUL CODY · CIK 0001258393 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 396,484 F1 · security: Restricted stock with three year vesting date. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 18:23 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 26,598 | $17.68 | $470,252.64 |
DisclosureSEC source: 0000075252-18-000025 · edgar.xml · nonDerivative · entry 1 PHIPPS PAUL CODY · CIK 0001258393 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,698 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. F2 · balance_after: Balance includes employee stock purchase plan holdings not previously reflected in beneficial ownership total. Read SEC document |
| July 03, 2017 Filed Jul 5, 2017 19:30 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 12,677 | $32.19 | $408,072.63 |
DisclosureSEC source: 0000075252-17-000102 · edgar.xml · nonDerivative · entry 1 PHIPPS PAUL CODY · CIK 0001258393 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,249 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| May 18, 2017 Filed May 22, 2017 16:28 UTC | RR Donnelley & Sons Co RRD · Entity 129856 | GrantCommon Stock | 11,589 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-034319 · doc4.xml · nonDerivative · entry 1 PHIPPS PAUL CODY · CIK 0001258393 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,450 F1 · price: Company granted restricted stock units issued pursuant to Rule 16b-3 Plan. The restricted stock units are payable in shares of common stock in which vest on May 18, 2018 or when the reporting person ceases to be a director, if earlier. F2 · balance_after: Includes 13,450 restricted stock units. Read SEC document |
| May 18, 2017 Filed May 21, 2018 17:40 UTC Amendment | RR Donnelley & Sons Co RRD · Entity 129856 | GrantCommon Stock | 11,589 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-032000 · doc4a.xml · nonDerivative · entry 1 PHIPPS PAUL CODY · CIK 0001258393 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,450 F1 · price: Company granted restricted stock units ("RSUs") issued pursuant to Rule 16b-3 Plan. The RSUs are payable in shares of common stock on the third anniversary of the grant date or when the reporting person ceases to be a director, if earlier. F2 · balance_after: Includes 13,450 RSUs. Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 18:08 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 23,824 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-17-000029 · edgar.xml · nonDerivative · entry 2 PHIPPS PAUL CODY · CIK 0001258393 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,985 F2 · security: Restricted stock vesting on 2/5/2018 F3 · balance_after: Balance includes employee stock purchase plan holdings not previously reflected in beneficial ownership total. Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 18:08 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 55,695 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-17-000029 · edgar.xml · nonDerivative · entry 1 PHIPPS PAUL CODY · CIK 0001258393 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,773 F1 · security: Restricted stock with three year vesting date. Read SEC document |
| February 09, 2017 Filed Mar 1, 2017 16:52 UTC Amendment | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 31,765 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-17-000043 · edgar.xml · nonDerivative · entry 1 PHIPPS PAUL CODY · CIK 0001258393 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,926 F1 · shares: Correction to amount of securities acquired due to administrative error. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 18:00 UTC | RR Donnelley & Sons Co RRD · Entity 129856 | GrantCommon Stock | 1,861 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-16-030948 · doc4.xml · nonDerivative · entry 1 PHIPPS PAUL CODY · CIK 0001258393 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,861 F1 · shares: P. Cody Phipps has been awarded 1,861 director restricted stock units ("RSUs"), pursuant to the R. R. Donnelley & Sons Company ("RRD") Non-Employee Director Compensation Plan, for his service on the RRD board of directors for the remainder of 2016. The RSUs are payable in shares of common stock one year from the date of grant or when the Reporting Person ceases to be a director, if earlier. The Reporting Person will amend this Form 4 when such information is available. F1 · balance_after: P. Cody Phipps has been awarded 1,861 director restricted stock units ("RSUs"), pursuant to the R. R. Donnelley & Sons Company ("RRD") Non-Employee Director Compensation Plan, for his service on the RRD board of directors for the remainder of 2016. The RSUs are payable in shares of common stock one year from the date of grant or when the Reporting Person ceases to be a director, if earlier. The Reporting Person will amend this Form 4 when such information is available. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.